---
filename: toxidromes-overdose-and-arrest-in-poisoning.md
id: toxidromes-overdose-and-arrest-in-poisoning
title: Toxidromes, Overdose & Arrest in Poisoning
slug: toxidromes-overdose-and-arrest-in-poisoning
tags: [toxicology, inpatient, night-float]
level: resident
estimated_time_min: 15
version: 2026-02-21
source: IM_NightFloat_Engine
---

# Toxidromes, Overdose & Arrest in Poisoning

## Panic Card
- Airway first: assess for hypoventilation; give **oxygen**, prepare for **rapid sequence intubation** if **GCS ≤8** or impending failure; avoid **succinylcholine** if hyperkalemia/rhabdomyolysis suspected.
- If opioid toxidrome: bag-mask ventilation, then **naloxone** titrated to respirations (e.g., **0.04–0.4 mg IV**, repeat to effect) without delaying **ACLS** if pulseless.
- Check **finger‑stick glucose**; if low, **dextrose 25–50 g IV**; give **thiamine 100 mg IV** before glucose if malnourished/heavy alcohol use.
- Seizures or severe agitation (sympathomimetic, isoniazid, theophylline): **benzodiazepines** first‑line; add **pyridoxine 5 g IV** for isoniazid.
- Wide QRS from sodium‑channel blockade (e.g., TCA, cocaine, diphenhydramine): **sodium bicarbonate 1–2 mEq/kg IV bolus**, target **pH 7.50–7.55** and QRS narrowing.
- Refractory cardiotoxicity from lipophilic agents (local anesthetics, some CCB/BB): consider **20% lipid emulsion** (**1.5 mL/kg bolus**, then **0.25 mL/kg/min**); escalate vasopressors; **MAP ≥65 mmHg**.

## Brief Overview
- Night‑float priorities: secure airway/ventilation, identify headline toxidrome (opioid, sympathomimetic, anticholinergic, cholinergic, sedative‑hypnotic, serotonin, sodium‑channel blockade), correct immediately reversible threats, and align with **AHA poisoning ACLS** modifications. **Guideline Must‑Know:** AHA special circumstances emphasize antidotes/support **without interrupting high‑quality CPR/defibrillation**.  
- **Guideline Must‑Know:** In suspected opioid‑associated emergencies, **CPR + ventilation** takes precedence; give **naloxone ASAP** but **do not delay CPR/AED**. Titrate naloxone to restore breathing to avoid precipitated withdrawal and pulmonary edema.  
- **Guideline Must‑Know:** For sodium‑channel blockade (e.g., TCA) with **QRS ≥100 ms** or tall **R in aVR**, treat with **IV sodium bicarbonate** boluses and alkalinization (**pH 7.50–7.55**); avoid class Ia/III antiarrhythmics; use **lidocaine** if ventricular arrhythmias persist.  
- **Guideline Must‑Know:** Severe **CCB/BB** overdose with cardiogenic shock warrants **high‑dose insulin euglycemia therapy (HIET)** early: typical start **1 U/kg regular insulin IV bolus**, then **0.5–1 U/kg/h** infusion with dextrose/electrolyte protocol; add calcium (for CCB), vasopressors, and consider **ECMO**.  
- **Guideline Must‑Know:** **Lipid emulsion** is reasonable for **local anesthetic systemic toxicity** and may be considered when **lipophilic xenobiotic toxicity** causes refractory instability despite standard care; monitor for pancreatitis and lab interference.  
- **Guideline Must‑Know:** **Activated charcoal** (single dose **50–100 g** adult) is **not routine**; consider within **≤1 h** of a potentially toxic ingestion if the **airway is protected**; beyond 1 h consider only if ongoing absorption (e.g., sustained‑release).  
- **Guideline Must‑Know:** **Whole bowel irrigation** (PEG‑ELS **1.5–2 L/h** adult) is a niche option for **sustained‑release/enteric‑coated** drugs, **iron**, or **body packers** when the airway is protected and no ileus/obstruction.  
- In **acetaminophen** ingestion, draw levels at **≥4 h** post-ingestion; start **N‑acetylcysteine** promptly when indicated and continue per stopping criteria; high‑risk “massive” ingestions may need modified protocols and adjuncts (e.g., fomepizole in select expert‑guided cases).  
- Cardiac arrest in poisoning: **ACLS core** plus **poison‑specific actions** (e.g., bicarb for sodium‑blockers, **calcium** for CCB, **glucagon** optional for BB, **lipid** for LAST). Consider **ECPR/ECMO** early for reversible, toxin‑mediated collapse if available.  
- **Confirm Before Proceed:** **Physostigmine** can rapidly reverse isolated central anticholinergic delirium but is **contraindicated** if **QRS ≥100 ms**, **AV/intraventricular block**, **TCA co‑ingestion**, or seizures; if used, give **0.5–1 mg IV over ≥5 min**, with **atropine at bedside**.  
- **Confirm Before Proceed:** **Flumazenil** is generally **avoided** in undifferentiated overdose due to **seizure risk** (mixed overdoses, BZD dependence, co‑ingested pro‑convulsants). Reserve for iatrogenic isolated benzodiazepine sedation in low‑risk settings.  
- Sympathomimetic toxicity (cocaine/meth): prioritize **aggressive benzodiazepine sedation**, **active cooling** if **T >40–41°C**, IV fluids for rhabdomyolysis; avoid pure **beta‑blockers** for hypertension/tachycardia; use **nitroglycerin**/**phentolamine** as needed.  
- For **organophosphates/carbamates** (cholinergic toxidrome): **atropine** titrated to **dry lungs** (start **1–2 mg IV**, double q3–5 min) and **pralidoxime** when indicated; anticipate copious secretions and need for early intubation.  
- Sedative‑hypnotic (GABAergic) overdoses: ensure **airway/ventilation**; avoid **flumazenil** except narrow indications; supportive care usually suffices.  
- Consider **EXTRIP** recommendations for dialyzable toxins (e.g., **salicylate**, **lithium**, **metformin**, **phenobarbital**); early nephrology input can be lifesaving.  
- “What must happen now” (first hour): airway/ventilation, ECG, glucose, core labs (BMP, **VBG/ABG**, lactate), targeted levels (acetaminophen, salicylate), antidotes, early call to **Poison Control (1‑800‑222‑1222)**, ICU if unstable.  
- “What can wait” (after stabilization): confirmatory tox screens, extended release imaging for body packing as needed, comprehensive psych/safety assessment, step‑down of insulin/pressors once hemodynamics stabilize.

## Top ICU/Consult Triggers
- Persistent or recurrent **hemodynamic instability** despite fluids and high‑dose vasopressors or need for **HIET/ECMO**.
- Refractory **seizures**, **hyperthermia >41°C**, or **severe metabolic acidosis** (**pH <7.2**) after initial measures.
- **QRS ≥160 ms**, malignant ventricular arrhythmias, or rising troponin/RV strain in suspected toxin‑induced cardiotoxicity.
- **Respiratory failure** requiring mechanical ventilation or escalating **FiO₂/PEEP**; impending airway from cholinergic secretions.
- **Acetaminophen** toxicity with **INR ≥2**, encephalopathy, or rising aminotransferases suggesting evolving **acute liver failure**.

## Orders to Place Now
- Order: Airway management — {prepare RSI; avoid succinylcholine if hyperkalemia/rhabdo risk; use rocuronium}
- Order: Naloxone — {0.04–0.4 mg IV titrate; may repeat q2–3 min; alternative 4 mg IN if no IV}
- Order: Sodium bicarbonate bolus — {1–2 mEq/kg IV push for QRS widening; repeat to QRS <100 ms; target pH 7.50–7.55}
- Order: High‑dose insulin euglycemia therapy — {regular insulin 1 U/kg IV bolus then 0.5–1 U/kg/h; start dextrose infusion; monitor glucose/K⁺/Mg²⁺/phosphate q15–60 min}
- Order: 20% lipid emulsion — {1.5 mL/kg IV bolus then 0.25 mL/kg/min; consider repeat bolus; max ~10 mL/kg; monitor triglycerides}
- Order: Activated charcoal — {50–100 g PO/NG once if ≤1 h since ingestion and airway protected}

## ABIM‑Style Question 1

### Stem
A 58‑year‑old man presents 90 minutes after ingesting an unknown amount of extended‑release verapamil. He is somnolent, BP 78/46 mmHg, HR 48 bpm, cool extremities, glucose 12.3 mmol/L, lactate 5.6 mmol/L. ECG shows sinus bradycardia without QRS widening. After 2 L crystalloid, **calcium chloride 1 g IV**, and norepinephrine to 0.2 μg/kg/min, he remains hypotensive.

### Options
A. Glucagon 5 mg IV bolus followed by 5 mg/h infusion  
B. Epinephrine infusion escalation alone  
C. High‑dose insulin euglycemia therapy (bolus **1 U/kg**, then **0.5–1 U/kg/h**)  
D. Lipid emulsion as first‑line therapy  
E. Atropine 1 mg IV q3 min up to 3 mg, then observe

### Correct answer
C

### Rationale
High‑dose insulin euglycemia therapy (HIET) is the **early** cornerstone for **CCB‑induced cardiogenic shock**, improving inotropy and metabolism; start **1 U/kg bolus then 0.5–1 U/kg/h** with dextrose and electrolyte monitoring. Calcium and catecholamines are adjuncts but often insufficient alone; glucagon is more useful for **β‑blocker** toxicity; lipid is considered when instability persists despite standard therapy. Guidelines and poison‑center protocols endorse early HIET in severe CCB toxicity with hypotension/bradycardia.

## Second ABIM‑Style Case (Pitfall Variant)

### Stem
A 32‑year‑old woman with severe agitated delirium, dry flushed skin, mydriasis, and urinary retention arrives after taking “sleeping pills.” ECG shows **QRS 128 ms** with tall terminal R in aVR. You consider physostigmine to reverse anticholinergic delirium.

### Options
A. Physostigmine 1 mg IV over 1 min with repeat dosing to effect  
B. Lorazepam and external cooling; observe  
C. Sodium bicarbonate **1–2 mEq/kg IV** bolus, repeat to QRS <100 ms, then reassess delirium  
D. Flumazenil 0.2 mg IV  
E. Haloperidol 10 mg IM

### Correct answer
C

### Rationale
The **pitfall** is administering **physostigmine** in the setting of **sodium‑channel blockade** (e.g., TCA/diphenhydramine) evidenced by **QRS ≥100 ms**/**R in aVR**; this risks bradyasystole and seizures. First treat membrane toxicity with **sodium bicarbonate** and alkalinization; delirium often improves as cardiotoxicity resolves. Flumazenil is contraindicated in mixed/unknown overdoses; high‑dose antipsychotics can worsen hyperthermia and lower seizure threshold.

What changed the decision here?

## Check‑Yourself Micro‑Questions
- Q: What QRS duration predicts seizures in TCA toxicity?  
  A: **QRS >100 ms** predicts seizures; **>160 ms** predicts ventricular arrhythmias.
- Q: Initial IV insulin bolus and infusion for HIET in severe CCB shock?  
  A: **1 U/kg IV bolus**, then **0.5–1 U/kg/h** infusion with dextrose and electrolytes monitored closely.
- Q: Preferred first‑line sedation for severe sympathomimetic toxicity with hyperthermia?  
  A: **Benzodiazepines** aggressively plus **active cooling**; avoid pure beta‑blockers for hypertension.
- Q: When is single‑dose activated charcoal reasonable?  
  A: Within **≤1 h** of a potentially toxic ingestion if the **airway is protected** or intubated, and the agent binds charcoal.
- Q: Opioid‑associated arrest—should naloxone delay CPR/defibrillation?  
  A: No; **start CPR/AED immediately** and give **naloxone as soon as available** without interrupting resuscitation.

## Guidelines & Key References
- American Heart Association. **2025 AHA Guidelines, Part 10: Special Circumstances of Resuscitation (Poisoning)**. Circulation. https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000001380
- American Heart Association. **2023 Focused Update on Adult ACLS & Management of Cardiac Arrest/Life‑Threatening Toxicity Due to Poisoning**. Summary: ABEM Clinical Policy Alert. https://www.abem.org/wp-content/uploads/2024/07/key-advances_-aha-updates-for-acls-2018-2019_clinical-policy-alert.pdf
- ACMT Position Statement. **Guidance for the Use of Intravenous Lipid Emulsion** (2016/2017). https://link.springer.com/content/pdf/10.1007/s13181-016-0550-z.pdf and ACMT Interim Guidance (2022). https://www.acmt.net/wp-content/uploads/2022/06/PRS_111001_Interim-Guidance-for-the-Use-of-Lipid-Resuscitation-Therapy.pdf
- AACT/EAPCCT. **Position Paper: Single‑Dose Activated Charcoal** (reaffirmed). https://www.clintox.org/wp-content/uploads/2016/04/Position-Statement-Single-Dose-Activated-Charcoal-1.pdf
- AACT/EAPCCT. **Position Paper Update: Whole Bowel Irrigation** (2015). https://www.clintox.org/wp-content/uploads/2016/04/Position-Statement-Whole-Bowel-Irrigation-1.pdf
- America’s Poison Centers, AACT, ACMT, CAPCCT. **Consensus Guidelines for Acetaminophen Poisoning** (2023). https://poisoncenters.org/news-alerts/13244374

## CDI: What to Document Clearly Tonight
- Acute toxic encephalopathy due to {specific agent/class} with intent {accidental/suicidal/undetermined}; complication(s) {respiratory failure/shock/seizures/arrhythmia}.
- Cardiotoxicity details: **QRS** {value}, rhythm/arrhythmia, **MAP**, vasopressor needs; interventions (bicarbonate, HIET, lipid, ECMO).
- Objective evidence: agent levels (e.g., acetaminophen, salicylate), ABG/VBG, lactate, creatinine kinase for rhabdomyolysis, temperature curve, imaging if applicable.
- Treatments/antidotes given with doses/titration: naloxone, sodium bicarbonate, calcium, insulin/dextrose protocol, lipid emulsion, benzodiazepines; response to therapy.
- Risk and safety: aspiration risk and airway protection status for decontamination; Poison Control consulted; monitoring plan (telemetry, serial ECGs, labs).
